PAVmed (PAVM) Competitors $0.69 +0.03 (+4.06%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$0.69 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. PTHL, MDAI, DXR, ECOR, POCI, NEPH, TMDIF, COCH, DRIO, and PYPDShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Spectral AI (MDAI), Daxor (DXR), electroCore (ECOR), Precision Optics (POCI), Nephros (NEPH), Titan Medical (TMDIF), Envoy Medical (COCH), DarioHealth (DRIO), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. PAVmed vs. Its Competitors Pheton Holdings Ltd Class A Ordinary Shares Spectral AI Daxor electroCore Precision Optics Nephros Titan Medical Envoy Medical DarioHealth PolyPid Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership. Does the MarketBeat Community prefer PTHL or PAVM? PAVmed received 205 more outperform votes than Pheton Holdings Ltd Class A Ordinary Shares when rated by MarketBeat users. Likewise, 66.34% of users gave PAVmed an outperform vote while only 0.00% of users gave Pheton Holdings Ltd Class A Ordinary Shares an outperform vote. CompanyUnderperformOutperformPheton Holdings Ltd Class A Ordinary SharesOutperform VotesNo VotesUnderperform Votes1100.00% PAVmedOutperform Votes20566.34% Underperform Votes10433.66% Is PTHL or PAVM more profitable? PAVmed has a net margin of 602.97% compared to Pheton Holdings Ltd Class A Ordinary Shares' net margin of 0.00%. Company Net Margins Return on Equity Return on Assets Pheton Holdings Ltd Class A Ordinary SharesN/A N/A N/A PAVmed 602.97%N/A -92.36% Which has higher earnings and valuation, PTHL or PAVM? Pheton Holdings Ltd Class A Ordinary Shares has higher earnings, but lower revenue than PAVmed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPheton Holdings Ltd Class A Ordinary Shares$448.20K242.16N/AN/AN/APAVmed$1.99M5.92-$64.18M$0.710.97 Do insiders and institutionals hold more shares of PTHL or PAVM? 19.9% of PAVmed shares are held by institutional investors. 7.3% of PAVmed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to PTHL or PAVM? In the previous week, Pheton Holdings Ltd Class A Ordinary Shares and Pheton Holdings Ltd Class A Ordinary Shares both had 4 articles in the media. Pheton Holdings Ltd Class A Ordinary Shares' average media sentiment score of 0.48 beat PAVmed's score of -0.04 indicating that Pheton Holdings Ltd Class A Ordinary Shares is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pheton Holdings Ltd Class A Ordinary Shares 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PAVmed 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate PTHL or PAVM? PAVmed has a consensus target price of $19.00, suggesting a potential upside of 2,653.62%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton Holdings Ltd Class A Ordinary Shares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryPAVmed beats Pheton Holdings Ltd Class A Ordinary Shares on 9 of the 12 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.79M$4.41B$5.57B$8.62BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-0.1628.4427.1720.06Price / Sales5.9271.85410.88157.10Price / CashN/A51.0838.2534.64Price / Book-0.215.917.094.70Net Income-$64.18M$67.63M$3.23B$247.88M7 Day Performance9.26%2.35%2.91%2.66%1 Month Performance-2.29%17.24%9.09%6.40%1 Year Performance-34.29%19.59%31.75%14.07% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed3.8026 of 5 stars$0.69+4.1%$19.00+2,653.6%-40.5%$11.79M$1.99M-0.1690PTHLPheton Holdings Ltd Class A Ordinary SharesN/A$6.29+1.5%N/AN/A$41.40M$448.20K0.0011High Trading VolumeMDAISpectral AI3.6472 of 5 stars$1.63+1.9%$4.75+191.4%+19.9%$41.27M$29.96M-2.5183News CoverageShort Interest ↓Gap UpDXRDaxor4.0142 of 5 stars$8.38+3.5%$25.00+198.3%-1.8%$40.53M$2.13M0.0037ECORelectroCore2.6015 of 5 stars$5.01+0.2%$25.50+409.0%-14.2%$37.10M$26.46M-2.7450POCIPrecision Optics0.3544 of 5 stars$4.66+7.8%N/A-22.5%$35.69M$17.63M-7.2780Short Interest ↑Gap UpNEPHNephros2.254 of 5 stars$3.13+15.1%$5.00+59.7%+71.9%$33.18M$15.52M-34.7830Short Interest ↑Gap UpHigh Trading VolumeTMDIFTitan MedicalN/A$0.29-0.2%N/A+550.0%$32.73M$17.63M-0.2350Gap DownCOCHEnvoy Medical2.3147 of 5 stars$1.50-1.4%$9.25+516.7%-41.8%$31.99M$212K-1.0934News CoveragePositive NewsShort Interest ↑DRIODarioHealth1.8303 of 5 stars$0.70-2.1%$2.00+185.7%-44.6%$31.13M$28.03M-0.74200Positive NewsPYPDPolyPid3.1596 of 5 stars$2.95+5.4%$11.33+284.2%-21.0%$30.06MN/A-0.5980Trending NewsAnalyst ForecastAnalyst RevisionGap DownHigh Trading Volume Related Companies and Tools Related Companies Pheton Holdings Ltd Class A Ordinary Shares Competitors Spectral AI Competitors Daxor Competitors electroCore Competitors Precision Optics Competitors Nephros Competitors Titan Medical Competitors Envoy Medical Competitors DarioHealth Competitors PolyPid Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAVM Stock Free PAVM Stock Alerts